Coegin Pharma
4.01
SEK
-1.72 %
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
1 following
-1.72%
-4.52%
-40.33%
-18.16%
-16.36%
-15.18%
-88.43%
+301%
-87.39%
www.coeginpharma.com/investor-relations
Coegin Pharma is a Swedish biotechnology company with dermacosmetic projects for hair growth and skin pigmentation, as well as drug candidates for the treatment of heart attacks and leukemia. What the projects have in common is that they are based on patented technology platforms and collaborations with researchers and academics internationally. Coegin Pharma has its headquarters in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Nordic SME
COEGIN
Daily low / high price
3.85 / 4.1
SEK
Market cap
99.76M SEK
Turnover
55.39K SEK
Volume
14K
Financial calendar
Annual report
2025-02-27
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Nordnet Pensionsförsäkring | 12.6 % | 12.6 % |
| Alveco Invest | 9.9 % | 9.9 % |
| Rune Löderup | 4.0 % | 4.0 % |
| Lennart Börjesson | 3.6 % | 3.6 % |
| Wilhelm Svenstig | 3.6 % | 3.6 % |
| Avanza Pension | 2.8 % | 2.8 % |
| Crystallus AB | 2.7 % | 2.7 % |
| Arctic Securities AS | 2.4 % | 2.4 % |
| Sparebank 1 Markets AS | 2.3 % | 2.3 % |
| Jens Eriksson | 2.1 % | 2.1 % |
ShowingAll content types
Coegin Pharmas valberedning utsedd inför årstämman 2025
Redeye: Coegin Pharma Q3 - Further business developments
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools